跳至主要内容
临床试验/NCT03081741
NCT03081741Unknown不适用

A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Lung Cancer Patients

Shenzhen Gene Health Bio Tech Co., Ltd.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2017年5月3日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
Effect of surgery on ctDNA of lung cancer patients

研究概览

简要总结

Conduct a prospective study to detect the change of ctDNA of surgical lung cancer patients.

详细描述

Studies have shown the feasibility of detecting mutation status by blood circulating tumor DNA (ctDNA) in lung cancer patients.

The investigators plan to test the blood ctDNA in surveillance of surgical lung cancer patients. And evaluate the correlation between ctDNA level with tumor relapse or metastasis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 80 years Undergo radical surgery Histologically confirmed diagnosis of lung cancer Considered primary lung cancer by clinical criteria Patients must have given written informed consent

排除标准

  • Unable to comply with the study procedure Malignant tumor history Patients who received any treatment prior to resection Unqualified blood samples

结局指标

主要结局

Effect of surgery on ctDNA of lung cancer patients

时间窗: before surgery and 7days after surgery

Changes of blood ctDNA of lung cancer patients before and after surgery.

次要结局

未报告次要终点

研究者

发起方
Shenzhen Gene Health Bio Tech Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验